机译:角质形成细胞生长因子(Palifermin)预防TBI基因造血干细胞移植中口腔粘膜炎的疗效和安全性。
Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;
Department of Haematology Oncology and Hemostaseology University Clinical Center University of;
Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;
Department of Haematology Oncology and Hemostaseology University Clinical Center University of;
Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;
Department of Haematology Oncology and Hemostaseology University Clinical Center University of;
WiSP Wissenschaftlicher Service Pharma GmbH Langenfeld Germany;
Department of Bone Marrow Transplantation West German Cancer Center Faculty of Medicine;
Department of Haematology Oncology Palliative Care University of Rostock Rostock Germany;
Department of Hematology Oncology and Tumorimmunology Charité - Universit?tsmedizin Berlin;
Internal Medicine C (Hematology and Oncology Palliative Care Transplant Centre) University;
Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;
Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;
机译:角质形成细胞生长因子(Palifermin)预防TBI基因造血干细胞移植中口腔粘膜炎的疗效和安全性。
机译:重组人角质形成细胞生长因子palifermin可减少口腔黏膜炎并改善干细胞移植后的患者预后。
机译:Palifermin:一种角质形成细胞生长因子,可减少干细胞移植后血液系统恶性肿瘤引起的口腔粘膜炎。
机译:外用光生物调节疗法预防小儿造血细胞移植患者的口咽粘膜炎
机译:自体干细胞移植患者口腔黏膜炎发生率和严重程度的影响因素。
机译:palifermin(角质形成细胞生长因子-1)在改善口腔粘膜炎中的功效
机译:角蛋白细胞生长因子(Palifermin)预防TBI基因造血干细胞移植中口服粘膜炎的疗效和安全性